摘要:
Performing graphics rendering without the computational expense of hither plane clipping and with only a minimum of display image clipping. Where a three dimensional polygon crosses to both sides of a hither plane, any vertices on the back side of the hither plane are translated to the hither plane, producing polygons which occupy only the area in front of the hither plane. A display image memory, from which display images are generated, is located within a larger guard memory such that many images which would need to be clipped to fit in the display image memory may be written to the guard memory without clipping.
摘要:
The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
摘要:
Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
摘要:
Compounds of formula (I): wherein R1, R2, R3, R4, A and n are as defined; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal).
摘要:
Compounds of formula (I) wherein R1, R2R3, R4, Λ, X, m and n are as defined; compositions comprising them, processes for preparing them and their use in medical therapy them and their use in medical therapy (for example mod ulating CCR5 receptor activity in a warm blooded animal).
摘要:
The present invention relates to compounds of formula (I) The compounds act via antagonism of the CCR2b receptor and may be used to treat inflammatory disease and/or neuropathic pain.
摘要:
Compounds of formula (I): compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating CCR5 receptor activity in a warm blooded animal)
摘要:
The invention provides a compound of formula (I): [Chemical formula should be inserted here. Please see paper copy.] wherein R1, R2, R3, R3a, R4, R4a, R5, and R6 are as defined; or a pharmaceutically acceptable salt thereof or a solvate thereof; compositions containing these compounds, processes for preparing them and their use as modulators of chemokine activity (especially CCR5 activity).